Hypophosphatemic rickets in opsismodysplasia

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 1, 2007, Pages 79-86

  Zeger, Martha Dechert ^a   Adkins, Deanna ^b   Fordham, Lynn A ^c   White, Kenneth E ^d   Schoenau, Eckhard ^e   Rauch, Frank ^f   Loechner, Karen J ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

FGF23; Hypophosphatemic rickets; Osteopenia; PHEX; Phosphatonin; Spondylo(epi)chondrodysplasia

Indexed keywords

CALCITRIOL; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; PHOSPHORUS; FIBROBLAST GROWTH FACTOR;

ARTICLE; BIOCHEMISTRY; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE RADIOGRAPHY; CASE REPORT; CHONDRODYSPLASIA; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HYPOPHOSPHATEMIA; MEDICAL EXAMINATION; METAPHYSIS; OPSISMODYSPLASIA; PHOSPHATE BLOOD LEVEL; PROTEIN ANALYSIS; RICKETS; BLOOD; PRESCHOOL CHILD; RADIOGRAPHY;

CHILD, PRESCHOOL; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIA; OSTEOCHONDRODYSPLASIAS; RICKETS;

EID: 34047247196     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.1.79     Document Type: Article

References (19)

1. Zonana J, Rimoin DL, Lachman RS, Cohen AH. A unique chondrodysplasia secondary to a defect in chondroosseous transformation. Birth Defects 1977; 13: 155-163.
2. Maroteaux P, Stanescu V, Stanescu R, Le Marec B, Moraine C, Lejarraga H. Opsismodysplasia: a new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebrae. Am J Med Gen 1984; 19: 171-182.
3. Spranger J, Brill PW, Poznanski AK. Bone Dysplasias, 2nd Ed. Oxford: Oxford University Press, 2002; 209-210.
4. Cormier-Daire V, Delezoide AL, Philip N, Marcorelles P, Casas K, Hillion Y, Faivre L, Rimoin DL, Munnich A, Maroteaux P, Le Merrer M. Clinical, radiological, and chondro-osseous findings in opsismodysplasia: survey of a series of 12 unreported cases. J Med Gen 2003; 40: 195-200.
5. Tyler K, Sarioglu N, Kunze J. Five familial cases of opsismodysplasia substantiate the hypothesis of autosomal recessive inheritance. Am J Med Gen 1999; 83: 47-52.
6. The HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 1995; 11: 130-136.
7. White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 2001; 60: 2079-2086.
8. Bai X, Dengshun M, Goltzman D, Karaplis AC. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 2003; 278: 9843-9849.
9. White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, Yu X, Shaw NJ, McLellan NJ, McKeown C, FitzPatrick D, Yu K, Ornitz DM, Econs MJ. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet 2005; 76: 361-367.
10. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002; 87: 4957-4960.
11. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003; 348: 1656-1663.
12. Ward LM, Rauch F, White KE, Filler G, Matzinger MA, Letts M, Travers R, Econs MJ, Glorieux FH. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone 2004; 34: 905-911.
13. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum FGF-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149.
14. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 2001; 138: 236-243.
15. Darendeliler F, Bas F, Karaaslan N, Hekim N, Bundak R, Saka N, Gunoz H. The effect of growth hormone treatment on biochemical indices in hypophosphatemic rickets. Horm Res 2001; 55: 191-195.
16. Mansfield K, Rajpurhoit R, Shapiro IM. Extracellular phosphate causes apoptosis of terminally differentiated chondrocytes. J Cell Physiol 1999; 179: 276-286.
17. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278: 37419-37426.
18. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561-568.
19. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112: 642-646.